Zobrazeno 1 - 10
of 429
pro vyhledávání: '"D.W. van Bekkum"'
Autor:
D.W. van Bekkum
Publikováno v:
Stem Cell Therapy for Autoimmune Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebb648fa7379956ce8ab5a39bf7533b9
https://doi.org/10.1201/9780367813895-29
https://doi.org/10.1201/9780367813895-29
Autor:
S. Garattini, D.W. van Bekkum
Scientists are coming under increasing pressure from activist groups to stop animal experimentation, branded as cruel and unnecessary for improving human health. This attitude, however, stems from an unrealistic evaluation of the situation and distor
Autor:
D.W. van Bekkum
Publikováno v:
Clinical Immunology and Immunopathology. 89:1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8439cc5a55923c159e943f805559e63a
https://doi.org/10.1006/clin.1998.4563
https://doi.org/10.1006/clin.1998.4563
Autor:
D.W. van Bekkum, M.C. Esandi, G.D. van Someren, Dinko Valerio, A. H. Mulder, A. Bout, J. L. Noteboom
Publikováno v:
Gene Therapy. 5:778-788
Cytokine gene therapy was studied in established L42 tumours in syngeneic rats. L42 is a transplantable non-immunogenic non-small cell lung cancer (NSCLC). Genes coding for human interleukin-1 alpha and for rat interleukin-3 beta were transferred by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da394dc0955543ac6c1405ff0b856fc9
https://doi.org/10.1038/sj.gt.3300662
https://doi.org/10.1038/sj.gt.3300662
Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene
Autor:
G.D. van Someren, A. Bout, M.C. Esandi, Arnaud J P E Vincent, Dinko Valerio, D.W. van Bekkum, J. L. Noteboom
Publikováno v:
Gene Therapy, 4, 280-287. Nature Publishing Group
Replication-defective adenovirus vectors were generated in which the gene of interest (lacZ, luciferase or HSV-tk) is driven by the adenovirus major late promoter (MLP) or the human cytomegalovirus immediate-early gene promoter/enhancer (CMV). In vit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4569e3efd39d7fd794c31657545dcc0c
https://doi.org/10.1038/sj.gt.3300385
https://doi.org/10.1038/sj.gt.3300385
Publikováno v:
Transplantation. 62:810-818
BUF rats suffering from severe relapsing experimental autoimmune encephalomyelitis (R-EAE), a model for multiple sclerosis, were treated with intensive cytoreductive therapy and grafting of allogeneic bone marrow (BM). BN.1B rats were used as EAE-res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b0a0ddfc273ebac03b82abc623c78be
https://doi.org/10.1097/00007890-199609270-00019
https://doi.org/10.1097/00007890-199609270-00019
Publikováno v:
Cellular Immunology. 168:39-48
To determine the feasibility of treatment with allogeneic bone marrow for experimental autoimmune encephalomyelitis, we investigated the susceptibility to experimental autoimmune encephalomyelitis of bone marrow chimeras using BUF, (WAG X BUF)F1 (hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc93c5dd02ca2b775f83124dc45c45f
https://doi.org/10.1006/cimm.1996.0047
https://doi.org/10.1006/cimm.1996.0047